Cargando…
T-Cell Engagers in Solid Cancers—Current Landscape and Future Directions
SIMPLE SUMMARY: There are multiple strategies to target cancer cells, and among the rapidly evolving field is the use of bispecific antibodies and T-cell engagers in the treatment of cancers. These drugs work by recruiting and activating T-cells, a type of white blood cell, to recognize and attack c...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216491/ https://www.ncbi.nlm.nih.gov/pubmed/37345160 http://dx.doi.org/10.3390/cancers15102824 |